View More View Less
  • 1 University of Medicine and Pharmacy “Iuliu Hatieganu” Physiology Department Cluj-Napoca Romania
  • | 2 National R&D Institute of Chemistry and Petrochemistry — ICECHIM Bucharest Romania
  • | 3 Oncologic Institute “I. Chiricuta” Cluj-Napoca Romania
  • | 4 District Hospital Morphopathology Department Cluj Napoca Romania
Restricted access

Purchase article

USD  $25.00

1 year subscription (Individual Only)

USD  $752.00

Photodynamic therapy (PDT) is a promising therapy especially in skin cancer, using the systemic administration of a photosensitizer (PS), followed by the local irradiation of the tumor with visible light. The antitumor effects of PDT are determined especially by the generation of cytotoxic reactive oxygen species (ROS). The 5,10,15,20-tetrasulfophenyl-porphyrin (TSPP) is a synthetic photosensitizer, which proved its efficiency in in vitro studies. Our study evaluates the effects of PDT with TSPP upon the tumor levels of ROS and upon the metalloproteinases 2 (MMP2) activities on Wistar male rats bearing 256 Walker carcinosarcoma in correlation with the accumulation of PS in the tumor and with the intratumor histological alterations. The evaluations were performed dynamically, at 3 hours, 6 hours, 24 hours and 14 days after the PDT with TSPP. Our results emphasize that 24 hours after the PDT with TSPP, the ROS generation increases, as revealed by protein carbonyls and malondialdehyde levels and the antioxidant capacity (hydrogen donors, thiol groups) decreases in the tumor tissue. These parameters were correlated with the appearance of the histological disorders. The MMP-2 activity increases exponentially in the 24 hours — 14 days post PDT interval. PDT with TSPP offers, in vivo, consistent results regarding ROS generation, MMP2 activation and cytotoxic capacity.

  • Alexandrova R, Ion RM, Stoykova E, Sheemlinkov S: In vitro investigation on cytotoxic activity of TS4PP (5,10,15,20-tetra(4-sulfophenyl) porphyrin. Proc. of SPIE. 5226, 423–427 (2003)

    Sheemlinkov S. , 'In vitro investigation on cytotoxic activity of TS4PP (5,10,15,20-tetra(4-sulfophenyl) porphyrin ' (2003 ) 5226 Proc. of SPIE. : 423 -427.

    • Search Google Scholar
  • Alexandrova R, Sabotinov O, Stoykova EV, Ion RM, Shurulnikov S, Minchev G: In vitro cytotoxicity assessment of [5, 10, 15, 20-tetra(4-sulfophenyl)-porphyrin] on tumor and nontumor cell lines. Proc. of SPIE. 5449, 227–234 (2004)

    Minchev G. , 'In vitro cytotoxicity assessment of [5, 10, 15, 20-tetra(4-sulfophenyl)-porphyrin] on tumor and nontumor cell lines ' (2004 ) 5449 Proc. of SPIE. : 227 -234.

    • Search Google Scholar
  • Bradford, MM: A rapid and sensitive method for the quantitation of microgram quantitites of protein utilizing the principle of protein-dye binding. Analytical Biochemistry 72, 248–254 (1976)

    Bradford M.M. , 'A rapid and sensitive method for the quantitation of microgram quantitites of protein utilizing the principle of protein-dye binding ' (1976 ) 72 Analytical Biochemistry : 248 -254.

    • Search Google Scholar
  • Calin MA, Ion RM, Herascu N: Kramers-Kronig analysis of 5, 10, 15, 20-tetra sulfophenyl-porphyrin. J. Optoelecton. Adv. Mater. 7(6), 3155–3160 (2005)

    Herascu N. , 'Kramers-Kronig analysis of 5, 10, 15, 20-tetra sulfophenyl-porphyrin ' (2005 ) 7 J. Optoelecton. Adv. Mater. : 3155 -3160.

    • Search Google Scholar
  • Constantin C, Neagu M, Manda G, Ion RM, Iordachescu DI: The effect of laser activation on 5, 10, 15, 20 — tetra sulphophenyl-porphyrin loaded in K 562 cells and human normal mononiclear cells. Roum. Arch. Microbiol. Immunol. 63(3–4), 159–168 (2004)

    Iordachescu D.I. , 'The effect of laser activation on 5, 10, 15, 20 — tetra sulphophenyl-porphyrin loaded in K 562 cells and human normal mononiclear cells ' (2004 ) 63 Roum. Arch. Microbiol. Immunol. : 159 -168.

    • Search Google Scholar
  • Conti M, Moran PC, Levillain P: Improved fluorimetric determination of malondialdehyde. Clin. Chem. 37, 1273–1275 (1991)

    Levillain P. , 'Improved fluorimetric determination of malondialdehyde ' (1991 ) 37 Clin. Chem. : 1273 -1275.

    • Search Google Scholar
  • Dougherty TJ, Gomer CJ, Henderson BW, et al: Photodynamic therapy. J. Natl. Cancer Inst. 90, 889–905 (1998)

    Henderson B.W. , 'Photodynamic therapy ' (1998 ) 90 J. Natl. Cancer Inst. : 889 -905.

  • Ferrario A, Chantrain C, Von Tiehl K, Buckley S, Rucker N, Shalinsky D, Shimada H, DeClerck YA, Gomer J: The matrix metalloproteinase inhibitor Prinomastat enhances photodynamic therapy responsiveness in a mouse tumor model. Cancer Res. 64, 2328–2332 (2004)

    Gomer J. , 'The matrix metalloproteinase inhibitor Prinomastat enhances photodynamic therapy responsiveness in a mouse tumor model ' (2004 ) 64 Cancer Res. : 2328 -2332.

    • Search Google Scholar
  • Filip A, Clichici S, Muresan A, Daicoviciu D, Tatomir C, Login C, Dreve S, Gherman C: Effects of photodynamic therapy with 5-aminolevulinic acid and chitosan on Walker carcinosarcoma. Exp. Oncol. 30(3), 1–8 (2008)

    Gherman C. , 'Effects of photodynamic therapy with 5-aminolevulinic acid and chitosan on Walker carcinosarcoma ' (2008 ) 30 Exp. Oncol. : 1 -8.

    • Search Google Scholar
  • Girotti AW, Kriska T: Role of lipid hydroperoxides in photo-oxidative stress signaling. Antioxid. Redox Signal. 6(2), 301–310 (2004)

    Kriska T. , 'Role of lipid hydroperoxides in photo-oxidative stress signaling ' (2004 ) 6 Antioxid. Redox Signal. : 301 -310.

    • Search Google Scholar
  • Girotti AW: Photosensitized oxidation of membrane lipids: reaction pathways, cytotoxic effects, and cytoprotective mechanisms. J. Photochem. Photobiol. B. 63(1–3), 103–113 (2001)

    Girotti A.W. , 'Photosensitized oxidation of membrane lipids: reaction pathways, cytotoxic effects, and cytoprotective mechanisms ' (2001 ) 63 J. Photochem. Photobiol. B. : 103 -113.

    • Search Google Scholar
  • Gomer CJ, Ferrario A, Luna M, Rucker N, Wong S: Photodynamic therapy: combined modality approaches targeting the tumor microenvironment. Lasers Surg. Med. 38(5), 516–521 (2006)

    Wong S. , 'Photodynamic therapy: combined modality approaches targeting the tumor microenvironment ' (2006 ) 38 Lasers Surg. Med. : 516 -521.

    • Search Google Scholar
  • Granelli-Piperno A, Reich E: A study of proteases and protease-inhibitor complexes in biological fluids. J. Exp. Med. 148, 223–234 (1978)

    Reich E. , 'A study of proteases and protease-inhibitor complexes in biological fluids ' (1978 ) 148 J. Exp. Med. : 223 -234.

    • Search Google Scholar
  • Heussen C, Dowdle EB: Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate copolymerized substrates. Anal. Biochem. 102(1), 196–202 (1980)

    Dowdle E.B. , 'Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate copolymerized substrates ' (1980 ) 102 Anal. Biochem. : 196 -202.

    • Search Google Scholar
  • Hu ML: Measurement of protein thiol groups and glutathione in plasma. Methods Enzymol. 233, 380–384 (1994)

    Hu M.L. , 'Measurement of protein thiol groups and glutathione in plasma ' (1994 ) 233 Methods Enzymol : 380 -384.

    • Search Google Scholar
  • Ion RM: Spectral studies of TSPP and TSNP used in PDT. Monomer-dimer equilibrium. Rom. J. Biophys. 6(3–4), 213–218 (1996)

    Ion R.M. , 'Spectral studies of TSPP and TSNP used in PDT. Monomer-dimer equilibrium ' (1996 ) 6 Rom. J. Biophys. : 213 -218.

    • Search Google Scholar
  • Ion RM: The spectral study of the porphyrins used in PDT. The aggregation processes. St. Cerc. Biotehnol. 29–30, 205–212 (1997)

    Ion R.M. , 'The spectral study of the porphyrins used in PDT. The aggregation processes ' (1997 ) 29–30 St. Cerc. Biotehnol. : 205 -212.

    • Search Google Scholar
  • Ion RM, Planner A, Wiktorowicz K, Frackowiak D: Incorporation of various porphyrins into blood cells measured via flow-cytometry, absorption and emission spectroscopy. Acta Biochim. Pol. 45(3), 833–845 (1998)

    Frackowiak D. , 'Incorporation of various porphyrins into blood cells measured via flow-cytometry, absorption and emission spectroscopy ' (1998 ) 45 Acta Biochim. Pol. : 833 -845.

    • Search Google Scholar
  • Ion RM, Grigorescu M, Scarlat FS, Niculescu AV, Gunnaydin K: Light, electron and photon irradiation of 5, 10, 15, 20-tetra (4-sulfophenyl) porphyrin used in cancer therapy. J. BUON. 5, 201–207 (2000)

    Gunnaydin K. , 'Light, electron and photon irradiation of 5, 10, 15, 20-tetra (4-sulfophenyl) porphyrin used in cancer therapy ' (2000 ) 5 J. BUON. : 201 -207.

    • Search Google Scholar
  • Ion RM, Brezoi DV: New nano-sized sensing drug and its clinical application. Solid State Phenomena. 106, 79–82 (2005)

    Brezoi D.V. , 'New nano-sized sensing drug and its clinical application ' (2005 ) 106 Solid State Phenomena : 79 -82.

    • Search Google Scholar
  • Ion RM: Photodynamic therapy (PDT): a photochemical concept with medical applications. Rev. Roum. Chim. 52(12), 1093–1102 (2007)

    Ion R.M. , 'Photodynamic therapy (PDT): a photochemical concept with medical applications ' (2007 ) 52 Rev. Roum. Chim. : 1093 -1102.

    • Search Google Scholar
  • Iosif A, Grummt UW: Aggregation of tetrakis (4-methylpyridyl)porphyrin and tetrakis(4-sulphonatophenyl) porphyrin in water. J. Prakt. Chem. 339, 420–425 (1997)

    Grummt U.W. , 'Aggregation of tetrakis (4-methylpyridyl)porphyrin and tetrakis(4-sulphonatophenyl) porphyrin in water ' (1997 ) 339 J. Prakt. Chem. : 420 -425.

    • Search Google Scholar
  • Janazsewska A, Bartosz G: Assay of antioxidant capacity: comparison of four methods as applied to human blood plasma. Scand. J. Lab. Invest. 62, 231–236 (2002)

    Bartosz G. , 'Assay of antioxidant capacity: comparison of four methods as applied to human blood plasma ' (2002 ) 62 Scand. J. Lab. Invest. : 231 -236.

    • Search Google Scholar
  • Jiraskova M, Jirasek L, Stork J, Vosmik F, Jirsa M: Photodynamic diagnosis and therapy in dermatology. Experience with use of TPPS4 in skin diseases. Cas. Lek. Cesk. 142(8), 493–499 (2003)

    Jirsa M. , 'Photodynamic diagnosis and therapy in dermatology. Experience with use of TPPS4 in skin diseases ' (2003 ) 142 Cas. Lek. Cesk. : 493 -499.

    • Search Google Scholar
  • Joshi PG, Joshi K, Joshi NB: Effect of hematoporphyrin derivate and light on sulfhydryl groups in brain tumour cells. Indian J. Exp. Biol. 33(10), 721–724 (1995)

    Joshi N.B. , 'Effect of hematoporphyrin derivate and light on sulfhydryl groups in brain tumour cells ' (1995 ) 33 Indian J. Exp. Biol. : 721 -724.

    • Search Google Scholar
  • Kemnitz K, Sakaguchi T: Water-soluble porphyrin monomer-dimmer systems: fluorescence dynamics and thermodynamic properties. Chem. Phys. Lett. 196, 497–503 (1992)

    Sakaguchi T. , 'Water-soluble porphyrin monomer-dimmer systems: fluorescence dynamics and thermodynamic properties ' (1992 ) 196 Chem. Phys. Lett. : 497 -503.

    • Search Google Scholar
  • Kim MM, Kim SK: Chitooligosaccharides inhibit activation and expression of matrix metalloproteinase-2 in human dermal fibroblasts. FEBS Lett. 15(580), 2661–2666 (2006)

    Kim S.K. , 'Chitooligosaccharides inhibit activation and expression of matrix metalloproteinase-2 in human dermal fibroblasts ' (2006 ) 15 FEBS Lett. : 2661 -2666.

    • Search Google Scholar
  • Kolarova H, Bajgar R, Tomankova K, Nevrelova P, Mosinger J: Comparison of sensitizers by detecting reactive oxygen species after photodynamic reaction in vitro. Toxicol. In Vitro 21(7), 1287–1291 (2007)

    Mosinger J. , 'Comparison of sensitizers by detecting reactive oxygen species after photodynamic reaction in vitro ' (2007 ) 21 Toxicol. In Vitro : 1287 -1291.

    • Search Google Scholar
  • Komagoe K, Tamagake K, Katsu T: The influence of aggregation of porphyrins on the efficiency of photogeneration of hydrogen peroxide in aqueous solution. Chem. Pharm. Bull. 54(7), 1004–1009 (2006)

    Katsu T. , 'The influence of aggregation of porphyrins on the efficiency of photogeneration of hydrogen peroxide in aqueous solution ' (2006 ) 54 Chem. Pharm. Bull. : 1004 -1009.

    • Search Google Scholar
  • Magi B, Ettorre A, Liberatori S, Bini L, Andreassi M, Frosali S, Neri P, Pallini V, Di Stefano A: Selectivity of protein carbonylation in the apoptotic response to oxidative stress associated with photodynamic therapy: a cell biochemical and proteomic investigation. Cell Death. Differ. 11(8), 842–852 (2004)

    Stefano A. , 'Selectivity of protein carbonylation in the apoptotic response to oxidative stress associated with photodynamic therapy: a cell biochemical and proteomic investigation ' (2004 ) 11 Cell Death. Differ. : 842 -852.

    • Search Google Scholar
  • Morton CA, Brown SB, Collins S, Ibbotson S, Jenkinson H, et al: Guidelines for topical photodynamic therapy: report of a workshop of the British Photodermatology Group. Br. J. Dermatol. 146(4), 552–567 (2002)

    Jenkinson H. , 'Guidelines for topical photodynamic therapy: report of a workshop of the British Photodermatology Group ' (2002 ) 146 Br. J. Dermatol. : 552 -567.

    • Search Google Scholar
  • Pazos MDC, Nader HB: Effect of photodynamic therapy on the extracellular matrix and associated components. Braz. J. Med. Biol. Res. 40(8), 1025–1035 (2007)

    Nader H.B. , 'Effect of photodynamic therapy on the extracellular matrix and associated components ' (2007 ) 40 Braz. J. Med. Biol. Res. : 1025 -1035.

    • Search Google Scholar
  • Reznick AZ, Packer L: Oxidative damage to proteins: spectrophotometric method for carbonyl assay. Methods Enzymol. 233, 357–363 (1994)

    Packer L. , 'Oxidative damage to proteins: spectrophotometric method for carbonyl assay ' (1994 ) 233 Methods Enzymol : 357 -363.

    • Search Google Scholar
  • Saczko J, Kulbacka J, Chwilkowska A, Lugowski M, Banas T: Levels of lipid peroxidation in A549 cells after PDT in vitro. Rocz. Akad. Med. Bialymst. 49(Suppl 1), 82–84 (2004)

    Banas T. , 'Levels of lipid peroxidation in A549 cells after PDT in vitro ' (2004 ) 49 Rocz. Akad. Med. Bialymst. : 82 -84.

    • Search Google Scholar
  • Schmidt-Erfurth U, Miller JW, Sickenberg M: Photodynamic therapy with Verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of retreatments in a Phases 1 and 2 study. Arch. Ophthalmol. 117, 1177–1178 (1999)

    Sickenberg M. , 'Photodynamic therapy with Verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of retreatments in a Phases 1 and 2 study ' (1999 ) 117 Arch. Ophthalmol. : 1177 -1178.

    • Search Google Scholar
  • Smith GJ, Ghiggino KP, Bennett LE, Nero TL: The “Q-band“ absorption spectra of hematoporphyrin monomer and aggregate in aqueous solution. Photochem. Photobiol. 49, 49–52 (1989)

    Nero T.L. , 'The “Q-band“ absorption spectra of hematoporphyrin monomer and aggregate in aqueous solution ' (1989 ) 49 Photochem. Photobiol. : 49 -52.

    • Search Google Scholar
  • Srivastava M, Ahmad N, Gupta S, Mukhtar H: Involvement of Bcl-2 and Bax in photodynamic therapy-mediated apoptosis. J. Biol. Chem. 276(18), 15481–15488 (2001)

    Mukhtar H. , 'Involvement of Bcl-2 and Bax in photodynamic therapy-mediated apoptosis ' (2001 ) 276 J. Biol. Chem. : 15481 -15488.

    • Search Google Scholar
  • Stoykova E, Nedkova K, Sabotonov O, Ion RM, Alexandrova R: In vitro cytotoxicity assessment of second generation photosensitizers for photodynamic therapy. J. Optoelectron. Adv. Mater. 9(2), 490–493 (2007)

    Alexandrova R. , 'In vitro cytotoxicity assessment of second generation photosensitizers for photodynamic therapy ' (2007 ) 9 J. Optoelectron. Adv. Mater. : 490 -493.

    • Search Google Scholar
  • Stoykova E, Sabotinov E, Ion RM, Alexandrova R: Reliability of the survival dose estimated from in vitro cytotoxicity testing in photodynamic therapy. Biotechnology & Biotechnological Equipment, 22(2), 754–758 (2008)

    Alexandrova R. , 'Reliability of the survival dose estimated from in vitro cytotoxicity testing in photodynamic therapy ' (2008 ) 22 Biotechnology & Biotechnological Equipment : 754 -758.

    • Search Google Scholar
  • Tatar O, Adam A, Shinoda K, Eckert T, Schariot GB et al: Matrix metalloproteinases in human choroidal neovascular membranes excised following verteporfin photodynamic therapy. Br. J. Ophthalmol. 91, 1183–1189 (2007)

    Schariot G.B. , 'Matrix metalloproteinases in human choroidal neovascular membranes excised following verteporfin photodynamic therapy ' (2007 ) 91 Br. J. Ophthalmol. : 1183 -1189.

    • Search Google Scholar
  • Tsaytler PA, CO’Flaherty M, Sakharov DV, Krijgsveld J, Egmond MR: Immediate protein targets of photodynamic treatment in carcinoma cells. J. Proteome Res. 7(9), 3868–3878 (2008)

    Egmond M.R. , 'Immediate protein targets of photodynamic treatment in carcinoma cells ' (2008 ) 7 J. Proteome Res. : 3868 -3878.

    • Search Google Scholar
  • Winkelman J: The distribution of tetraphenylporfinesulfonate in the tumor-bearing rat. Cancer Res. 22, 589–596 (1962)

    Winkelman J. , 'The distribution of tetraphenylporfinesulfonate in the tumor-bearing rat ' (1962 ) 22 Cancer Res. : 589 -596.

    • Search Google Scholar

The author instruction is available in PDF.

Please, download the file from HERE

Senior editors

Editor(s)-in-Chief: Rosivall, László

Honorary Editor(s)-in-Chief): Monos, Emil

Managing Editor(s): Bartha, Jenő; Berhidi, Anna

Co-editor(s): Koller, Ákos; Lénárd, László; Szénási, Gábor

Assistant Editor(s): G. Dörnyei (Budapest), Zs. Miklós (Budapest), Gy. Nádasy (Budapest)

Hungarian Editorial Board

      Benedek, György (Szeged)
      Benyó, Zoltán (Budapest)
      Boros, Mihály (Szeged)
      Chernoch, László (Debrecen)
      Détári, László (Budapest)
      Hamar, János (Budapest)
      Hantos, Zoltán (Szeged)
      Hunyady, László (Budapest)
      Imre, Sándor (Debrecen)
      Jancsó, Gábor (Szeged)
      Karádi, Zoltán (Pécs)
      Kovács, László (Debrecen)
      Palkovits, Miklós (Budapest)
      Papp, Gyula (Szeged)
      Pavlik, Gábor (Budapest)
      Spät, András (Budapest)
      Szabó, Gyula (Szeged)
      Szelényi, Zoltán (Pécs)
      Szolcsányi, János (Pécs)
      Szollár, Lajos (Budapest)
      Szücs, Géza (Debrecen)
      Telegdy, Gyula (Szeged)
      Toldi, József (Szeged)
      Tósaki, Árpád (Debrecen)

International Editorial Board

      R. Bauer (Jena)
      W. Benjelloun (Rabat)
      A. W. Cowley Jr. (Milwaukee)
      D. Djuric (Belgrade)
      C. Fry (London)
      S. Greenwald (London)
      O. Hänninen (Kuopio)
      H. G. Hinghofer-Szalkay (Graz)
      Th. Kenner (Graz)
      Gy. Kunos (Richmond)
      M. Mahmoudian (Tehran)
      T. Mano (Seki, Gifu)
      G. Navar (New Orleans)
      H. Nishino (Nagoya)
      O. Petersen (Liverpool)
      U. Pohl (Münich)
      R. S. Reneman (Maastricht)
      A. Romanovsky (Phoenix)
      G. M. Rubanyi (Richmond)
      T. Sakata (Oita)
      A. Siddiqui (Karachi)
      Cs. Szabo (Beverly)
      E. Vicaut (Paris)
      N. Westerhof (Amsterdam)
      L. F. Zhang (Xi'an)

Editorial Office:
Akadémiai Kiadó Zrt.
Prielle Kornélia u. 21–35, H-1117 Budapest, Hungary

Editorial Correspondence:
Acta Physiologica Hungarica
Semmelweis University, Faculty of Medicine Institute of Pathophysiology
Nagyvárad tér 4, H-1089 Budapest, Hungary
Phone/Fax: +36-1-2100-100
E-mail: aph@semmelweis-univ.hu

Indexing and Abstracting Services:

  • Biological Abstracts
  • BIOSIS Previews
  • CAB Abstracts
  • Chemical Abstracts
  • EMBASE/Excerpta Medica
  • Global Health
  • Index Copernicus
  • Index Medicus
  • Medline
  • Referativnyi Zhurnal
  • Science Citation Index Expanded
  • SCOPUS

 

Acta Physiologica Hungarica
Language English
Size  
Year of
Foundation
1950
Publication
Programme
changed title
Volumes
per Year
 
Issues
per Year
 
Founder Magyar Tudományos Akadémia
Founder's
Address
H-1051 Budapest, Hungary, Széchenyi István tér 9.
Publisher Akadémiai Kiadó
Publisher's
Address
H-1117 Budapest, Hungary 1516 Budapest, PO Box 245.
Responsible
Publisher
Chief Executive Officer, Akadémiai Kiadó
ISSN 0231-424X (Print)
ISSN 1588-2683 (Online)

Monthly Content Usage

Abstract Views Full Text Views PDF Downloads
May 2021 6 0 0
Jun 2021 8 0 0
Jul 2021 11 0 0
Aug 2021 13 0 0
Sep 2021 0 0 0
Oct 2021 12 0 0
Nov 2021 0 0 0